Hostname: page-component-7d684dbfc8-mqbnt Total loading time: 0 Render date: 2023-10-01T13:13:08.725Z Has data issue: false Feature Flags: { "corePageComponentGetUserInfoFromSharedSession": true, "coreDisableEcommerce": false, "coreDisableSocialShare": false, "coreDisableEcommerceForArticlePurchase": false, "coreDisableEcommerceForBookPurchase": false, "coreDisableEcommerceForElementPurchase": false, "coreUseNewShare": true, "useRatesEcommerce": true } hasContentIssue false

Does genotype and equol-production status affect response to isoflavones? Data from a pan-European study on the effects of isoflavones on cardiovascular risk markers in post-menopausal women

Published online by Cambridge University Press:  07 March 2007

Katerina Vafeiadou*
Hugh Sinclair Unit of Human Nutrition, School of Food Biosciences, Whiteknights, University of Reading, Reading RG6 6AP, UK
Wendy L. Hall
Hugh Sinclair Unit of Human Nutrition, School of Food Biosciences, Whiteknights, University of Reading, Reading RG6 6AP, UK
Christine M. Williams
Hugh Sinclair Unit of Human Nutrition, School of Food Biosciences, Whiteknights, University of Reading, Reading RG6 6AP, UK
*Corresponding author: Katerina Vafeiadou, fax +44 118 9310080, email
Rights & Permissions [Opens in a new window]


Core share and HTML view are not possible as this article does not have html content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The increase in CVD incidence following the menopause is associated with oestrogen loss. Dietary isoflavones are thought to be cardioprotective via their oestrogenic and oestrogen receptor-independent effects, but evidence to support this role is scarce. Individual variation in response to diet may be considerable and can obscure potential beneficial effects in a sample population; in particular, the response to isoflavone treatment may vary according to genotype and equol-production status. The effects of isoflavone supplementation (50 mg/d) on a range of established and novel biomarkers of CVD, including markers of lipid and glucose metabolism and inflammatory biomarkers, have been investigated in a placebo-controlled 2×8-week randomised cross-over study in 117 healthy post-menopausal women. Responsiveness to isoflavone supplementation according to (1) single nucleotide polymorphisms in a range of key CVD genes, including oestrogen receptor (ER) α and β and (2) equol-production status has been examined. Isoflavones supplementation was found to have no effect on markers of lipids and glucose metabolism. Isoflavones improve C-reactive protein concentrations but do not affect other plasma inflammatory markers. There are no differences in response to isoflavones according to equol-production status. However, differences in HDL-cholesterol and vascular cell adhesion molecule 1 response to isoflavones v. placebo are evident with specific ERβ genotypes. In conclusion, isoflavones have beneficial effects on C-reactive protein, but not other cardiovascular risk markers. However, specific ERβ gene polymorphic subgroups may benefit from isoflavone supplementation.

Postgraduate Symposium
Copyright © The Nutrition Society 2006


Atkinson, C, Frankenfeld, CL & Lampe, JW (2005) Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Experimental Biology and Medicine 230 155170.Google ScholarPubMed
Atkinson, C, Oosthuizen, W, Scollen, S, Loktionov, A, Day, NE & Bingham, SA (2004) Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49–65 year-old women. Journal of Nutrition 134 17591764.Google ScholarPubMed
Beral, V, Bull, D & Reeves, G (2005) Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365 15431551.Google ScholarPubMed
Blakesmith, SJ, Lyons-Wall, PM, George, C, Joannou, GE, Petocz, P & Samman, S (2003) Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women. British Journal of Nutrition 89 467474.CrossRefGoogle ScholarPubMed
Blann, AD, Bushell, D, Davies, A, Faragher, EB, Miller, JP & McCollum, CN (1993) von Willebrand factor, the endothelium and obesity. International Journal of Obesity and Related Metabolic Disorders 17 723725.Google ScholarPubMed
Brinton, EA (1996) Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arteriosclerosis, Thrombosis, and Vascular Biology 16 431440.CrossRefGoogle ScholarPubMed
Burman, A, Jain, K, Gulati, R, Chopra, V, Agarwal, DP & Vasisht, S (2004) Lipoprotein(a) as a marker of coronary artery disease and its association with dietary fat. Journal of the Association of Physicians of India 52 99102.Google ScholarPubMed
Campbell, MJ, Woodside, JV, Honour, JW, Morton, MS & Leathem, AJ (2004) Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study. European Journal of Clinical Nutrition 58 173179.CrossRefGoogle ScholarPubMed
Cheng, SY, Shaw, NS, Tsai, KS & Chen, CY (2004) The hypoglycemic effects of soy isoflavones on postmenopausal women. Journal of Women's Health 13 10801086.CrossRefGoogle ScholarPubMed
Cushman, M, Legault, C, Barrett-Connor, E, Stefanick, ML, Kessler, C, Judd, HL, Sakkinen, PA & Tracy, RP (1999) Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 100 717722.CrossRefGoogle ScholarPubMed
Davies, IG, Graham, JM & Griffin, BA (2003) Rapid separation of LDL subclasses by iodixanol gradient ultracentrifugation. Clinical Chemistry 49 18651872.CrossRefGoogle ScholarPubMed
Dewell, A, Hollenbeck, CB & Bruce, B (2002) The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. Journal of Clinical Endocrinology and Metabolism 87 118121.CrossRefGoogle ScholarPubMed
Erberich, LC, Alcantara, VM, Picheth, G & Scartezini, M (2002) Hormone replacement therapy in postmenopausal women and its effects on plasma lipid levels. Clinical Chemistry and Laboratory Medicine 40 446451.CrossRefGoogle ScholarPubMed
Gottstein, N, Ewins, BA, Eccleston, C, Hubbard, GP, Kavanagh, IC, Minihane, AM, Weinberg, PD & Rimbach, G (2003) Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. British Journal of Nutrition 89 607616.CrossRefGoogle ScholarPubMed
Grady, D, Herrington, D, Bittner, V, Blumenthal, R, Davidson, M, Hlatky, M et al. (2002) Cardiovascular disease outcomes during 6·8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). Journal of the American Medical Association 288 4957.CrossRefGoogle Scholar
Hall, WL, Vafeiadou, K, Hallund, J, Bugel, S, Koebnick, C, Reimann, M et al. (2005) Soy isoflavone enriched foods and inflammatory biomarkers of cardiovascular risk in postmenopausal women: interactions with genotype and equol production. American Journal of Clinical Nutrition (In the Press).Google ScholarPubMed
Han, KK, Soares, JM Jr, Haidar, MA, de Lima, GR & Baracat, EC (2002) Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology 99 389394.Google ScholarPubMed
Hermansen, K, Sondergaard, M, Hoie, L, Carstensen, M & Brock, B (2001) Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24 228233.CrossRefGoogle ScholarPubMed
Herrington, DM, Howard, TD, Brosnihan, KB, McDonnell, DP, Li, X, Hawkins, GA, Reboussin, DM, Xu, J, Zheng, SL, Meyers, DA & Bleecker, ER (2002 a) Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105 18791882.CrossRefGoogle Scholar
Herrington, DM, Howard, TD, Hawkins, GA, Reboussin, DM, Xu, J, Zheng, SL, Brosnihan, KB, Meyers, DA, Bleecker, ER (2002 b) Estrogen-receptor polymorphisms and effects of estrogen replacement therapy in women with coronary heart disease. New England Journal of Medicine 346 967974.CrossRefGoogle Scholar
Hodgson, JM, Puddey, IB, Beilin, LJ, Mori, TA & Croft, KD (1998) Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. Journal of Nutrition 128 728732.Google Scholar
Hopkins, PN, Wu, LL, Hunt, SC & Brinton, EA (2005) Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. Journal of the American College of Cardiology 45 10031012.CrossRefGoogle ScholarPubMed
Howes, JB, Sullivan, D, Lai, N, Nestel, P, Pomeroy, S, West, L, Eden, JA & Howes, LG (2000) The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152 143157.CrossRefGoogle ScholarPubMed
Hwang, SJ, Ballantyne, CM, Sharrett, AR, Smith, LC, Davis, CE, Gotto, AM Jr & Boerwinkle, E (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96 42194225.CrossRefGoogle ScholarPubMed
Koh, KK, Bui, MN, Mincemoyer, R, Cannon, RO 3rd (1997) Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women. American Journal of Cardiology 80 15051507.CrossRefGoogle ScholarPubMed
Krasinski, K, Spyridopoulos, I, Asahara, T, van der Zee, R, Isner, JM & Losordo, DW (1997) Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 95 17681772.CrossRefGoogle ScholarPubMed
Kuiper, GG, Lemmen, JG, Carlsson, B, Corton, JC, Safe, SH, van der Saag, PT, van der Burg, B, Gustafsson, J-Å (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 42524263.CrossRefGoogle ScholarPubMed
Lakka, HM, Laaksonen, DE, Lakka, TA, Niskanen, LK, Kumpusalo, E, Tuomilehto, J & Salonen, JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 288 27092716.CrossRefGoogle ScholarPubMed
Lampe, JW, Karr, SC, Hutchins, AM & Slavin, JL (1998) Urinary equol excretion with a soy challenge: influence of habitual die. Proceedings of the Society for Experimental Biology and Medicine 217 335339.CrossRefGoogle Scholar
Manning, PJ, Sutherland, WHF, Allum, AR, de Jong, SA & Jones, SD (2002) Effect of hormone replacement therapy on inflammation-sensitive proteins in post-menopausal women with Type 2 diabetes. Diabetic Medicine 19 847852.CrossRefGoogle ScholarPubMed
Masson, LF & McNeill, G (2005) The effect of genetic variation on the lipid response to dietary change: recent findings. Current Opinion in Lipidology 16 6167.CrossRefGoogle ScholarPubMed
Matthews, DR, Hosker, JP, Rudenski, AS, Naylor, BA, Treacher, DF & Turner, RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 412419.CrossRefGoogle ScholarPubMed
Mobasseri, S, Liebson, PR & Klein, LW (2004) Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective. Cardiology in Review 12 287298.CrossRefGoogle ScholarPubMed
Mori, M, Tsukahara, F, Yoshioka, T, Irie, K & Ohta, H (2004) Suppression by 17beta-estradiol of monocyte adhesion to vascular endothelial cells is mediated by estrogen receptors. Life Sciences 75 599609.CrossRefGoogle ScholarPubMed
Morito, K, Hirose, T, Kinjo, J, Hirakawa, T, Okawa, M, Nohara, T, Ogawa, S, Inoue, S, Muramatsu, M & Masamune, Y (2001) Interaction of phytoestrogens with estrogen receptors alpha and beta. Biological and Pharmaceutical Bulletin 24 351356.CrossRefGoogle ScholarPubMed
Muthyala, RS, Ju, YH, Sheng, S, Williams, LD, Doerge, DR, Katzenellenbogen, BS, Helferich, WG & Katzenellenbogen, JA (2004) Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorganic and Medicinal Chemistry 12 15591567.CrossRefGoogle ScholarPubMed
Nagata, C, Takatsuka, N, Kawakami, N & Shimizu, H (2001) Soy product intake and hot flashes in Japanese women: Results from a community-based prospective study. American Journal of Epidemiology 153 790793.CrossRefGoogle ScholarPubMed
Nelson, HD, Humphrey, LL, Nygren, P, Teutsch, SM & Allan, JD (2002) Postmenopausal hormone replacement therapy: scientific review. Journal of the American Medical Association 288 872881.CrossRefGoogle ScholarPubMed
Nestel, PJ, Pomeroy, S, Kay, S, Komesaroff, P, Behrsing, J, Cameron, JD & West, L (1999) Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. Journal of Clinical Endocrinology and Metabolism 84 895898.Google Scholar
Nestel, PJ, Yamashita, T, Sasahara, T, Pomeroy, S, Dart, A, Komesaroff, P, Owen, A & Abbey, M (1997) Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology 17 33923398.CrossRefGoogle Scholar
Nikander, E, Metsa-Heikkila, M, Tiitinen, A & Ylikorkala, O (2003) Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 88 51805185.CrossRefGoogle ScholarPubMed
Nikander, E, Tiitinen, A, Laitinen, K, Tikkanen, M & Ylikorkala, O (2004) Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 89 35673572.CrossRefGoogle ScholarPubMed
Nilsson, M, Naessen, S, Dahlman, I, Linden Hirschberg, A, Gustafsson, J-Å, Dahlman-Wright, K (2004) Association of estrogen receptor beta gene polymorphisms with bulimic disease in women. Molecular Psychiatry 9 2834.CrossRefGoogle ScholarPubMed
Ogawa, S, Inoue, S, Watanabe, T, Orimo, A, Hosoi, T, Ouchi, Y & Muramatsu, M (1998) Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor of estrogen action in human. Nucleic Acids Research 26 35053512.CrossRefGoogle ScholarPubMed
Palmieri, C, Lam, EW, Mansi, J, MacDonald, C, Shousha, S, Madden, P, Omoto, Y, Sunters, A, Warner, M, Gustafsson, J-Å & Coombes, RC (2004) The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survival. Clinical Cancer Research 10 24212428.CrossRefGoogle Scholar
Ridker, PM, Hennekens, CH, Buring, JE & Rifai, N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine 23 836843.CrossRefGoogle Scholar
Rimbach, G, De Pascual-Teresa, S, Ewins, BA, Matsugo, S, Uchida, Y, Minihane, AM, Turner, R, Vafeiadou, K & Weinberg, PD (2003) Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica 33 913925.CrossRefGoogle ScholarPubMed
Rimbach, G, Weinberg, PD, de Pascual-Teresa, S, Alonso, MG, Ewins, BA, Turner, R et al. (2004) Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function. Biochimica et Biophysica Acta 1670 229237.CrossRefGoogle ScholarPubMed
Rosenkranz, K, Hinney, A, Ziegler, A, Hermann, H, Fichter, M, Mayer, H, Siegfried, W, Young, JK, Remschmidt, H & Hebebrand, J (1998) Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants. Journal of Clinical Endocrinology and Metabolism 83 45244527.CrossRefGoogle ScholarPubMed
Rowland, IR, Wiseman, H, Sanders, TAB, Adlercreutz, H & Bowey, EA (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutrition and Cancer 36 2732.CrossRefGoogle ScholarPubMed
Setchell, KD, Brown, NM, Lydeking-Olsen, E (2002) The clinical importance of the metabolite equol–a clue to the effectiveness of soy and its isoflavones. Journal of Nutrition 132 35773584.Google ScholarPubMed
Simons, LA, von Konigsmark, M, Simons, J & Celermajer, DS (2000) Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. American Journal of Cardiology 85 12971301.CrossRefGoogle ScholarPubMed
Sites, CK, L'Hommedieu, GD, Toth, MJ, Brochu, M, Cooper, BC & Fairhurst, PA (2005) The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 90 27012707.CrossRefGoogle ScholarPubMed
Squadrito, F, Altavilla, D, Crisafulli, A, Saitta, A, Cucinotta, D, Morabito, N, D'Anna, R, Corrado, F, Ruggeri, P, Frisina, N & Squadrito, G (2003) Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. American Journal of Medicine 114 470476.CrossRefGoogle ScholarPubMed
Squadrito, F, Altavilla, D, Morabito, N, Crisafulli, A, D'Anna, R, Corrado, F, Ruggeri, P, Campo, GM, Calapai, G, Caputi, AP & Squadrito, G (2002) The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 163 339347.CrossRefGoogle ScholarPubMed
Teede, HJ, McGrath, BP, DeSilva, L, Cehun, M, Fassoulakis, A & Nestel, PJ (2003) Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology 23 10661071.CrossRefGoogle ScholarPubMed
Tousoulis, D, Charakida, M & Stefanadis, C (2005) Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure. International Journal of Cardiology 100 347353.CrossRefGoogle ScholarPubMed
Wilcox, JG, Hatch, IE, Gentzschein, E, Stanczyk, FZ & Lobo, RA (1997) Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardioVascular risk factors. Fertility and Sterility 67 273277.CrossRefGoogle ScholarPubMed